ArticleBasic and clinical neuroscience

Dalteparin as a Novel Therapeutic Agent to Prevent Diabetic Encephalopathy by Targeting Oxidative Stress and Inflammation.

Motahareh Zeinivand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.